ProfileGDS4814 / ILMN_1667577
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 91% 91% 92% 91% 92% 92% 91% 92% 91% 91% 92% 91% 92% 92% 92% 92% 92% 92% 92% 92% 91% 92% 92% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)464.80791
GSM780708Untreated after 4 days (C2_1)494.56391
GSM780709Untreated after 4 days (C3_1)505.96892
GSM780719Untreated after 4 days (C1_2)466.25391
GSM780720Untreated after 4 days (C2_2)518.59392
GSM780721Untreated after 4 days (C3_2)560.47292
GSM780710Trastuzumab treated after 4 days (T1_1)460.31591
GSM780711Trastuzumab treated after 4 days (T2_1)511.20592
GSM780712Trastuzumab treated after 4 days (T3_1)467.79391
GSM780722Trastuzumab treated after 4 days (T1_2)453.94291
GSM780723Trastuzumab treated after 4 days (T2_2)535.42892
GSM780724Trastuzumab treated after 4 days (T3_2)452.00491
GSM780713Pertuzumab treated after 4 days (P1_1)512.31792
GSM780714Pertuzumab treated after 4 days (P2_1)540.31592
GSM780715Pertuzumab treated after 4 days (P3_1)516.02292
GSM780725Pertuzumab treated after 4 days (P1_2)523.66192
GSM780726Pertuzumab treated after 4 days (P2_2)514.12492
GSM780727Pertuzumab treated after 4 days (P3_2)551.53692
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)550.46492
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)513.97492
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)461.28491
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)510.01592
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)543.85692